Lee Johnson Capital Management LLC Has $3.84 Million Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

Lee Johnson Capital Management LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2,032.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,294 shares of the biotechnology company's stock after acquiring an additional 6,952 shares during the period. Axon Enterprise accounts for about 2.0% of Lee Johnson Capital Management LLC's investment portfolio, making the stock its 15th largest position. Lee Johnson Capital Management LLC's holdings in Axon Enterprise were worth $3,836,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the stock. Fourth Dimension Wealth LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. Bartlett & CO. Wealth Management LLC increased its position in Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new stake in Axon Enterprise during the 1st quarter worth approximately $32,000. Alpine Bank Wealth Management acquired a new stake in Axon Enterprise during the 1st quarter worth approximately $40,000. Finally, Elequin Capital LP acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $46,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

AXON stock traded down $11.94 during mid-day trading on Tuesday, reaching $790.22. The company had a trading volume of 507,731 shares, compared to its average volume of 705,489. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $61.52 billion, a P/E ratio of 190.87, a P/E/G ratio of 91.57 and a beta of 1.29. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $830.21. The stock's 50-day simple moving average is $740.97 and its two-hundred day simple moving average is $637.30.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same period last year, the business posted $1.15 earnings per share. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 9,905 shares of Axon Enterprise stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the transaction, the president directly owned 298,809 shares of the company's stock, valued at $220,530,006.27. The trade was a 3.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO Cameron Brooks sold 3,000 shares of Axon Enterprise stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $740.76, for a total value of $2,222,280.00. Following the transaction, the executive directly owned 19,447 shares in the company, valued at approximately $14,405,559.72. The trade was a 13.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 44,642 shares of company stock valued at $30,500,428. 5.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Bank of America increased their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Wolfe Research began coverage on shares of Axon Enterprise in a research report on Monday. They issued an "outperform" rating for the company. Finally, Barclays increased their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $699.55.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.